Recent Quarter Total Invested
$2.58 B
Recent Quarter Institutional Ownership Percentage
118.22%
Total Invested of Last Quarter
$3.18 B
Ownership Percentage of Last Quarter
117.73%
Celldex Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 8.08 M | $298.89 M | 5.60% | 13.72% |
| FMR LLC | 08/13/2024 | 7.83 M | $289.76 M | -19.50% | 13.30% |
| BLACKROCK INC. | 08/13/2024 | 4.69 M | $173.61 M | 3.96% | 7.97% |
| VANGUARD GROUP INC | 08/13/2024 | 3.74 M | $138.38 M | 2.42% | 6.35% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2024 | 3.39 M | $125.43 M | 16.86% | 5.76% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 3.33 M | $123.14 M | 6.67% | 5.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 3.17 M | $117.41 M | 2.76% | 5.39% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 3.08 M | $113.87 M | 0.57% | 5.23% |
| BELLEVUE GROUP AG | 08/14/2024 | 2.97 M | $109.98 M | 6.26% | 5.05% |
| STATE STREET CORP | 08/14/2024 | 2.66 M | $98.41 M | -10.76% | 4.52% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 1.94 M | $71.73 M | 50.96% | 3.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.53 M | $56.78 M | 8.45% | 2.61% |
| COMMODORE CAPITAL LP | 08/14/2024 | 1.43 M | $52.74 M | 64.46% | 2.42% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.40 M | $51.78 M | 1.95% | 2.38% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.38 M | $51.21 M | -7.44% | 2.35% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.38 M | $50.99 M | 53.30% | 2.34% |
| JENNISON ASSOCIATES LLC | 08/05/2024 | 1.00 M | $37.12 M | 45.78% | 1.70% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 874,193 | $32.35 M | 54.78% | 1.48% |
| NOVO HOLDINGS A/S | 08/20/2024 | 850,000 | $31.46 M | 100.00% | 1.44% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 845,560 | $31.29 M | 47.52% | 1.44% |
| WOODLINE PARTNERS LP | 08/14/2024 | 757,771 | $28.05 M | 0.89% | 1.29% |
| REDMILE GROUP, LLC | 08/14/2024 | 718,723 | $26.60 M | -19.83% | 1.22% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 650,000 | $24.06 M | 0.00% | 1.10% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 633,015 | $23.43 M | -10.98% | 1.08% |
| SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 547,707 | $20.27 M | -31.69% | 0.93% |
| NORTHERN TRUST CORP | 08/14/2024 | 545,594 | $20.19 M | -1.49% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 530,443 | $19.63 M | 6.25% | 0.90% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 497,270 | $18.40 M | 0.00% | 0.84% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 475,400 | $17.59 M | -6.78% | 0.81% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 431,880 | $15.98 M | 17.01% | 0.73% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 416,000 | $15.40 M | 128.48% | 0.71% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 374,910 | $13.88 M | 25.26% | 0.64% |
| CITADEL ADVISORS LLC | 08/14/2024 | 321,212 | $11.89 M | 275.92% | 0.55% |
| CANDRIAM S.C.A. | 08/05/2024 | 317,509 | $11.75 M | 0.00% | 0.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 309,265 | $11.45 M | 11.65% | 0.53% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 290,850 | $10.76 M | 16.89% | 0.49% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 07/23/2024 | 249,220 | $9.22 M | 0.00% | 0.42% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 247,644 | $9.17 M | 0.00% | 0.42% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 247,111 | $9.15 M | -9.02% | 0.42% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 230,162 | $8.52 M | 14.60% | 0.39% |
| EMERALD ADVISERS, LLC | 08/06/2024 | 198,429 | $7.34 M | -6.42% | 0.34% |
| JANE STREET GROUP, LLC | 08/15/2024 | 190,329 | $7.04 M | 7.60% | 0.32% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 189,678 | $7.02 M | -15.88% | 0.32% |
| NATIXIS | 08/13/2024 | 165,500 | $6.13 M | -22.63% | 0.28% |
| MORGAN STANLEY | 08/14/2024 | 163,992 | $6.07 M | -56.40% | 0.28% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 163,007 | $6.03 M | 50.25% | 0.28% |
| UBS GROUP AG | 08/14/2024 | 160,596 | $5.94 M | -37.35% | 0.27% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 144,467 | $5.35 M | 100.00% | 0.25% |
| AXA S.A. | 08/14/2024 | 142,290 | $5.27 M | 0.06% | 0.24% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 139,162 | $5.15 M | 53.04% | 0.24% |
Celldex Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CLDX shares?
During the previous two years, 237 institutional investors and hedge funds held shares of Celldex Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 8.08 M
FMR LLC: 7.83 M
BlackRock Inc.: 4.69 M
VANGUARD GROUP INC: 3.74 M
Kynam Capital Management, LP: 3.39 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.33 M
-
What percentage of Celldex Therapeutics, Inc. stock is owned by institutional investors?
118.22% of Celldex Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CLDX ?
Institutional investors have bought a total of 72.84 M shares in the last 24 months. This purchase volume represents approximately $2.37 B in transactions.